Olink publishes 2022 annual report

Rhea-AI Summary

Olink Holding AB (Nasdaq: OLK) has released its Annual Report for 2022, now accessible on its website. The report outlines the company's ongoing commitment to advancing proteomics in collaboration with the scientific community, aiming to facilitate new discoveries across various disease areas. Founded in 2016 and headquartered in Uppsala, Sweden, Olink operates internationally, providing a platform of products and services utilized by major biopharmaceutical companies, clinical, and academic institutions. This initiative is designed to enhance the understanding of human biology and drive impactful healthcare advancements.

Positive

• Olink's 2022 Annual Report is now available, providing insights into the company's operations and initiatives.
• The company continues to develop its proteomics platform, which is increasingly deployed across major biopharmaceutical and academic institutions.

Negative

• None.

UPPSALA, Sweden, March 27, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Annual Report for 2022 is now available on the Company’s website at https://investors.olink.com/.

About Olink
Olink Holding AB (publ) (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The Company was founded in 2016 and is well established across Europe, North America, and Asia. Olink is headquartered in Uppsala, Sweden.

IR contact
Jan Medina, CFA, VP Investor Relations & Capital Markets
Mobile: +1 617 802 4157
jan.medina@olink.com

Media contact
Andrea Prander, Corporate Communications Manager
Mobile: +46 768 775 275
andrea.prander@olink.com

FAQ

Where can I find Olink's 2022 Annual Report?

Olink's 2022 Annual Report is available on their website at https://investors.olink.com.

What is the focus of Olink Holding AB?

Olink is dedicated to accelerating proteomics to enable new discoveries in various disease areas.

When was Olink Holding AB founded?

Olink was founded in 2016 and is headquartered in Uppsala, Sweden.

What stock exchange is Olink listed on?

Olink is listed on the Nasdaq stock exchange under the ticker symbol OLK.